China Bozza Development Holdings Limited (HK:1069)
:1069
Want to see HK:1069 full AI Analyst Report?
Top Page
China Bozza Development Holdings Limited
(1069)
Select Model
Select Model
Rating:48Neutral
Price Target:
HK$0.31
▼(-32.17% Downside)
Action:Reiterated
Date:05/15/26
Overall score reflects high financial risk as the dominant factor: leverage remains heavy and core profitability signals are weak (negative EBIT/EBITDA and thin margins), even with a revenue rebound and improved operating cash flow. Technical indicators are mildly weak-to-neutral, while valuation looks optically inexpensive due to a very low P/E.
Positive Factors
Revenue Rebound
A strong revenue rebound in FY2025 indicates the company can regain scale after prior downturns, supporting capacity utilization and pricing leverage. Sustained top-line recovery over several quarters would underpin fixed-cost absorption and improve long-term earnings power if maintained.
Negative Factors
High Leverage
Persistently high debt-to-equity in FY2025 leaves the firm vulnerable to interest-cost increases and refinancing risk in an asset-heavy, cyclical industry. Elevated leverage constrains strategic flexibility, raises bankruptcy risk in downturns, and limits ability to fund growth without diluting equity.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Rebound
A strong revenue rebound in FY2025 indicates the company can regain scale after prior downturns, supporting capacity utilization and pricing leverage. Sustained top-line recovery over several quarters would underpin fixed-cost absorption and improve long-term earnings power if maintained.
Read all positive factors
China Bozza Development Holdings Limited (1069) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$94.18M
Dividend YieldN/A
Average Volume (3M)417.79K
Price to Earnings (P/E)1.1
Beta (1Y)1.05
Revenue Growth56.25%
EPS Growth496.46%
CountryHK
Employees33
SectorBasic Materials
Sector Strength58
IndustryPaper, Lumber & Forest Products
Share Statistics
EPS (TTM)0.28
Shares Outstanding308,772,670
10 Day Avg. Volume214,500
30 Day Avg. Volume417,794
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)1.30
Price to Sales (P/S)0.33
P/FCF Ratio-33.74
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
China Bozza Development Holdings Limited Business Overview & Revenue Model
Company Description
China Health Technology Group Holding Co., Ltd. functions as an investment firm, concentrating its efforts on forestry management. Its activities include the cultivation, felling, and commercialization of timber goods. The organization was establi...
How the Company Makes Money
null...
China Bozza Development Holdings Limited Financial Statement Overview
Summary
Income Statement
46
Neutral
Balance Sheet
28
Negative
Cash Flow
52
Neutral
| Breakdown | TTM | Jun 2024 | Jun 2024 | Dec 2022 | Jun 2022 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 94.60M | 97.39M | 47.61M | 58.72M | 6.76M | 6.67M |
| Gross Profit | 8.62M | 8.87M | 1.90M | 11.51M | 0.00 | 6.67M |
| EBITDA | -7.74M | -7.74M | 208.39M | -42.17M | -9.85M | -48.36M |
| Net Income | 24.03M | 24.52M | 200.01M | -10.80M | -18.90M | -268.54M |
Balance Sheet | ||||||
| Total Assets | 225.04M | 191.09M | 178.17M | 140.64M | 93.52M | 491.54M |
| Cash, Cash Equivalents and Short-Term Investments | 4.92M | 2.68M | 3.23M | 4.33M | 1.11M | 134.00K |
| Total Debt | 127.45M | 115.23M | 119.11M | 356.77M | 321.97M | 333.44M |
| Total Liabilities | 173.86M | 166.22M | 165.20M | 457.35M | 400.15M | 369.48M |
| Stockholders Equity | 51.18M | 24.87M | 12.96M | -316.71M | -306.63M | 122.06M |
Cash Flow | ||||||
| Free Cash Flow | 1.77M | -959.71K | 28.63M | 22.16M | -466.00K | -5.58M |
| Operating Cash Flow | 1.77M | 37.43M | 28.86M | 23.44M | -466.00K | -5.58M |
| Investing Cash Flow | -6.15M | -38.34M | -26.49M | -23.26M | 2.00K | -410.00K |
| Financing Cash Flow | 3.83M | 2.29M | -3.47M | 3.04M | -249.00K | -3.29M |
China Bozza Development Holdings Limited Technical Analysis
Neutral
0.46
Price Trends
0.29
Positive
0.32
Negative
0.35
Negative
Market Momentum
>-0.01
Negative
50.78
Neutral
45.45
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1069, the sentiment is Neutral. The current price of 0.46 is above the 20-day moving average (MA) of 0.30, above the 50-day MA of 0.29, and above the 200-day MA of 0.35, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 50.78 is Neutral, neither overbought nor oversold. The STOCH value of 45.45 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for HK:1069.
China Bozza Development Holdings Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
59 Neutral | HK$12.76B | 6.57 | 6.55% | 3.92% | 2.49% | 47.91% | |
48 Neutral | HK$94.18M | 1.08 | 44.96% | ― | 56.25% | 496.46% | |
48 Neutral | HK$30.31B | 7.87 | 7.39% | ― | 7.38% | 252.52% | |
47 Neutral | HK$1.09B | 5.87 | 3.27% | 3.45% | -3.12% | -41.12% | |
45 Neutral | HK$721.45M | -11.74 | -37.51% | ― | 9.60% | -399.43% | |
42 Neutral | HK$4.85B | -0.88 | ― | ― | -48.87% | 16.69% |
* Basic Materials Sector Average
HK:1069
China Bozza Development Holdings Limited
0.31
-0.08
-21.59%
HK:2314
Lee & Man Paper Manufacturing
2.97
0.82
38.27%
HK:2689
Nine Dragons Paper Holdings
6.46
3.24
100.62%
HK:1812
Shandong Chenming Paper Holdings Co., Ltd. Class H
0.73
0.07
10.61%
HK:2002
China Sunshine Paper Holdings Co. Ltd.
1.02
-0.73
-41.71%
HK:0731
C&D Newin Paper & Pulp Corporation Limited
0.51
0.31
158.88%
China Bozza Development Holdings Limited Corporate Events
China Health Technology Wins Shareholder Backing for Rights Issue and Placing
May 12, 2026
China Health Technology Group Holding Company Limited secured shareholder approval at an extraordinary general meeting on 12 May 2026 for a proposed rights issue and a placing agreement. The resolutions were passed by poll with 100% of votes cast ...
China Health Technology Shifts EGM Venue to Shenzhen, Keeps All Other Arrangements Unchanged
Apr 30, 2026
China Health Technology Group Holding Company Limited has announced a change in the venue for its extraordinary general meeting scheduled for 3:30 p.m. on 12 May 2026, shifting the event to Suite 1702, 17/F, Tower A, Bojin Business Plaza, Chegongm...
China Health Technology Plans Major Rights Issue and Placement to Raise Equity
Apr 23, 2026
China Health Technology Group Holding Company Limited has called an extraordinary general meeting in Shenzhen on 12 May 2026 to seek shareholder approval for a sizeable rights issue. The company plans to issue up to 205,848,440 new shares at HK$0....
China Bozza to Raise Up to HK$51.5 Million via Non-Underwritten Rights Issue
Mar 27, 2026
China Bozza Development Holdings Limited plans to raise up to approximately HK$51.5 million through a rights issue on the basis of two rights shares for every one existing share at a subscription price of HK$0.25 per rights share. The offer will b...
China Health Technology Group Posts Modest Profit Growth on Higher Revenue
Feb 27, 2026
China Health Technology Group reported interim unaudited revenue of RMB34.4 million for the six months ended 31 December 2025, up from RMB31.1 million a year earlier, as gross profit rose to RMB4.1 million from RMB2.8 million. Profit for the perio...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.